The form of selenium determines the response to supplementation in a selenium replete population.
In an ongoing study of selenium bioavailability, effects of supplementation with organic and inorganic forms of selenium were investigated in healthy, Norwegian women, aged 23-50 years. In phase I of the study, 58 women received 200 micrograms selenium per day either as selenite or selenium-rich pea flour for 3 months. The selenium tablets were taken together with placebo or ascorbic acid in a double blind design. Initial blood and serum selenium concentrations were 153 +/- 15 micrograms/l and 117 +/- 12 micrograms/l, respectively. These are average values for Norwegians. Indications of increased blood levels were seen in all groups, but the rise reached significance only for the subgroup receiving selenite and ascorbic acid, 14 micrograms/l, P less than 0.05. On the other hand, selenium analysis of 72-h urine samples confirmed that at an average 50 per cent of the selenium supplements had been absorbed. In phase II of the study, 28 of the participants continued for another 5 weeks, still on 200 micrograms Se per day, but this time consuming commercially available preparations. Of four preparations that were tested, two consisted of yeast Se. Only one of these produced a significant rise in blood and serum selenium levels, 60 and 55 micrograms/l respectively. Blood glutathione peroxidase values were not affected by any supplementation. The study demonstrates that different forms of organic selenium elicit widely different responses when administered to a relatively selenium-replete population, and that the explanation for this must be sought at the metabolic level.
Meltzer
H M
HM
Institute for Nutrition Research, University of Oslo, School of Medicine, Norway.
Norheim
G
G
Bibow
K
K
Myhre
K
K
Holm
H
H
D000328:Adult; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000493:pharmacokinetics; D001682:Biological Availability; D004032:Diet; D005260:Female; D006801:Humans; D008875:Middle Aged; D009752:Nutritional Status; D012643:Selenium / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*
D012643:Selenium; D001205:Ascorbic Acid